|
1
|
Vijayan VK: Chronic obstructive pulmonary
disease. Indian J Med Res. 137:251–269. 2013.PubMed/NCBI
|
|
2
|
Barczyk A and Pierzchala W: Diagnostic and
treatment of chronic obstructive pulmonary disease based on GOLD
statement 2011. Pol Merkur Lekarski. 33:187–192. 2012.(In Polish).
PubMed/NCBI
|
|
3
|
Fletcher C and Peto R: The natural history
of chronic airflow obstruction. Br Med J. 1:1645–1648. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Faner R, Gonzalez N, Cruz T, Kalko SG and
Agusti A: Systemic inflammatory response to smoking in chronic
obstructive pulmonary disease: evidence of a gender effect. PLoS
One. 9:e974912014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moher D, Liberati A, Tetzlaff J and Altman
DGPRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: the PRISMA statement. PLoS Med. 6:e10000972009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Issac MS, Ashur W and Mousa H: Genetic
polymorphisms of surfactant protein D rs2243639, Interleukin
(IL)-1beta rs16944 and IL-1RN rs2234663 in chronic obstructive
pulmonary disease, healthy smokers, and non-smokers. Mol Diagn
Ther. 18:343–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Liu X, Xu Y, et al: The correlation
of vitamin D level and vitamin D-binding protein gene polymorphism
in chronic obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi.
53:303–307. 2014.(In Chinese). PubMed/NCBI
|
|
8
|
Kauffmann F, Kleisbauer JP,
Cambon-De-Mouzon A, et al: Genetic markers in chronic air-flow
limitation. A genetic epidemiologic study. Am Rev Respir Dis.
127:263–269. 1983.PubMed/NCBI
|
|
9
|
Ito I, Nagai S, Hoshino Y, et al: Risk and
severity of COPD is associated with the group-specific component of
serum globulin 1F allele. Chest. 125:63–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen LH, Zhang XM, Su DJ, et al:
Association of vitamin D binding protein variants with
susceptibility to chronic obstructive pulmonary disease. J Int Med
Res. 38:1093–1098. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McLeod JF and Cooke NE: The vitamin
D-binding protein, alpha-fetoprotein, albumin multigene family:
detection of transcripts in multiple tissues. J Biol Chem.
264:21760–21769. 1989.PubMed/NCBI
|
|
12
|
Kew RR, Sibug MA, Liuzzo JP and Webster
RO: Localization and quantitation of the vitamin D binding protein
(Gc-globulin) in human neutrophils. Blood. 82:274–283.
1993.PubMed/NCBI
|
|
13
|
Yamamoto N and Homma S: Vitamin D3 binding
protein (group-specific component) is a precursor for the
macrophage-activating signal factor from
lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci
USA. 88:8539–8543. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Binder R, Kress A, Kan G, Herrmann K and
Kirschfink M: Neutrophil priming by cytokines and vitamin D binding
protein (Gc-globulin): impact on C5a-mediated chemotaxis,
degranulation and respiratory burst. Mol Immunol. 36:885–892. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McLeod JF, Kowalski MA and Haddad JG Jr:
Interactions among serum vitamin D binding protein, monomeric
actin, profilin, and profilactin. J Biol Chem. 264:1260–1267.
1989.PubMed/NCBI
|
|
16
|
Janssens W, Bouillon R, Claes B, et al:
Vitamin D deficiency is highly prevalent in COPD and correlates
with variants in the vitamin D-binding gene. Thorax. 65:215–220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Janssens W, Lehouck A, Carremans C,
Bouillon R, Mathieu C and Decramer M: Vitamin D beyond bones in
chronic obstructive pulmonary disease: time to act. Am J Respir
Crit Care Med. 179:630–636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cleve H and Constans J: The mutants of the
vitamin-D-binding protein: more than 120 variants of the GC/DBP
system. Vox Sang. 54:215–225. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang P, Ma Y, Du X, Chen J, Song B and
Hong Y: The vitamin D-binding protein gene polymorphism in chronic
obstructive pulmonary disease patients. Zhonghua Jie He He Hu Xi Za
Zhi. 30:780–781. 2007.(In Chinese).
|
|
20
|
Ishii T, Keicho N, Teramoto S, et al:
Association of Gc-globulin variation with susceptibility to COPD
and diffuse panbronchiolitis. Eur Respir J. 18:753–757. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Korytina GF, Akhmadishina LZ, Ianbaeva DG
and Viktorova TV: Genotypes of vitamin-D-binding protein (DBP) in
patients with chronic obstructive pulmonary disease and healthy
population of Republic Bashkortostan. Mol Biol (Mosk). 40:231–238.
2006.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu M, Yang B and Cai YY: The relationship
between vitamin D binding protein gene polymorphism and chronic
obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi. 43:117–120.
2004.(In Chinese). PubMed/NCBI
|
|
23
|
Schellenberg D, Pare PD, Weir TD, Spinelli
JJ, Walker BA and Sandford AJ: Vitamin D binding protein variants
and the risk of COPD. Am J Respir Crit Care Med. 157:957–961. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wood AM, Bassford C, Webster D, et al:
Vitamin D-binding protein contributes to COPD by activation of
alveolar macrophages. Thorax. 66:205–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laufs J, Andrason H, Sigvaldason A, et al:
Association of vitamin D binding protein variants with chronic
mucus hypersecretion in Iceland. Am J Pharmacogenomics. 4:63–68.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Der Simonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
29
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kueppers F, Miller RD, Gordon H, Hepper NG
and Offord K: Familial prevalence of chronic obstructive pulmonary
disease in a matched pair study. Am J Med. 63:336–342. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Horne SL, Cockcroft DW and Dosman JA:
Possible protective effect against chronic obstructive airways
disease by the GC2 allele. Hum Hered. 40:173–176. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wood AM, Needham M, Simmonds MJ, Newby PR,
Gough SC and Stockley RA: Phenotypic differences in alpha 1
antitrypsin-deficient sibling pairs may relate to genetic
variation. COPD. 5:353–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bakke PS, Zhu G, Gulsvik A, et al:
Candidate genes for COPD in two large data sets. Eur Respir J.
37:255–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
